AUROBINDO PHARMA LTD vs ZYDUS LIFESCIENCES LTD
A side-by-side comparison of AUROBINDO PHARMA LTD (AUROPHARMA) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, ZYDUS LIFESCIENCES LTD leads AUROPHARMA vs ZYDUSLIFE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability04
- Growth02
- Size & financial health22
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
AUROPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ZYDUSLIFE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ZYDUSLIFE takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
EvenScale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["Stock is trading at 2.52 times its book value", "The company has delivered a poor sales growth of 6.32% over past five years.", "Company has a low return on equity of 10.8% over last 3 years.", "Company might be capitalizing the interest cost"]
- + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.